Clinical trial Recruiting at 1 site Interventional Ages 15 to 49 Women only

Mittin intervention to improve contraceptive side effect counseling and follow-up in Addis Ababa

Official title: Cluster Randomized Controlled Trial of the "Mittin" Intervention in Addis Ababa, Ethiopia

Run by University of California, San Francisco · NCT07301281 · Data updated 2026-11-12

Aims to see if the Mittin program helps women who use hormonal methods or copper IUDs in Addis Ababa better manage their contraception according to their preferences.

Quick facts

Study typeInterventional
Ages15 Years to 49 Years
SexWomen only
Enrollment2715 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (Addis Ababa)
StatusRecruiting
StartedFebruary 23, 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedJuly 23, 2026
Trial IDNCT07301281 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 15-49 in Addis Ababa who started or continued a hormonal method or copper IUD and are willing to provide contact information for follow-up.

Probably not a fit

Individuals not planning to stay in Addis Ababa for eight months or who cannot verbally communicate or provide consent may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial tests whether the Mittin program, added to standard contraception services, helps women aged 15-49 in Addis Ababa align their contraceptive choices with their preferences and improve satisfaction. Participants are randomized by site to receive either standard care or enhanced Mittin services, with surveys at enrollment, 4 months, and 8 months to gauge outcomes. The study is conducted at public health centers in Addis Ababa and is led by UCSF with Ethiopian collaborators and funders. The objective is to determine if Mittin improves preference-aligned fertility management and continued method use. No phase information is provided for this study.

Why it matters

Potential benefit: If successful, Mittin could help women choose and continue contraception that matches their preferences and reduces side-effect concerns.

How similar studies have gone: Previous studies in contraceptive counseling and follow-up show potential benefits of enhanced patient-centered support, but Mittin’s specific approach is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Woman
* Started or continued using hormonal contraceptive method or copper IUD on day of recruitment
* Ages 15-49 years
* Willing to provide phone number and receive follow-up phone call

Exclusion Criteria:

* Not planning to live in Addis Ababa for the next eight months
* Can not verbally communicate
* Not willing to provide consent for the study

Where it's running

  • St. Paul's Hospital Millennium Medical College
    Addis Ababa, Ethiopia
    Recruiting

Study contacts

  • Principal investigator: Kelsey Holt, ScD — University of California, San Francisco
  • Study coordinator: Kelsey Holt, ScD
  • Email: kelsey.holt@ucsf.edu
  • Phone: 617-455-2693

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.